Objectives-This study was aimed to assess the ultrasound (US) characteristics of mycosis fungoides (MF)/Sézary syndrome (SS) and explore the value of high-frequency US in accuracy staging for classic mycosis fungoides (cMF). Methods-A prospective study was designed. Twenty-six patients with histopathologically confirmed MF or SS were enrolled to undergo HF-US examinations. Both 50-and 20-MHz US images of the most prominent lesion of each patient were collected by a cutaneous diagnostic US system, and the US characteristics in different stages were analyzed by 2 physicians independently. The Fisher exact test was used for the statistical analysis. Results-A total of 26 patients underwent this study, including 23 with cMF, 2 with folliculotropic mycosis fungoides (FMF), and 1 with SS. Among cMF, 16 patients with patches or plaques (the early-stage group) showed a subepidermal low-echogenic band, and only 3 lesions in the plaque stage partially extended to the superficial dermis. Seven patients with tumors (the advancedstage group) showed lesions that infiltrated to the deep dermis or subcutaneous tissue. The infiltration depth (P < .001), clarity of the boundary (P = .002), and homogeneity of internal echoes (P = .001) were significantly different between the early and advanced stages. Additionally, the 2 FMF lesions and 1 SS lesion had characteristic manifestations, showing a well-defined subepidermal lowechogenic band with patchy hypoechoic regions around the hair follicles in the dermis. Conclusions-High-frequency US can be used to accurately detect the infiltration depth and morphologic features of MF/SS lesions and provide important information for tumor staging of cMF. Additionally, the characteristic US features in FMF and SS might be helpful for diagnosis. Key Words-cutaneous lymphoma; high-frequency ultrasound; mycosis fungoides; Sézary syndrome M ycosis fungoides (MF) and Sézary syndrome (SS) are typical types of cutaneous T-cell lymphoma (CTCL). Mycosis fungoides and its variants are the most common types of CTCL, approximately accounting for 60% of cases. On clinical assessment, classic mycosis fungoides (cMF) lesions can be classified into patch, plaque, and tumor stages. Patients with SS commonly have rapidly progressing erythroderma with generalized lymphadenopathy. Accurate staging is an important prerequisite for individualized treatment of patients with MF. At present, skin lesions are classified into different stages mainly through inspection and